Acquisitions and Joint Ventures (Tables)

12 Months Ended

Dec. 31, 2017

Schedule Of Purchase Price Allocations Table

The following table summarizes the aggregate consideration paid for the acquisitions and the amounts of the assets acquired and liabilities assumed at the acquisition dates, as well as their fair value at the acquisition dates and the noncontrolling interest acquired (amounts in thousands):



Consideration
Cash	$	75,028
Fair value of total consideration transferred	75,028
Recognized amounts of identifiable assets acquired and liabilities assumed
Patient account receivable	5,679
Trade name	14,238
Certificates of needs/licenses	20,207
Other identifiable intangible assets	6
Other assets and (liabilities), net	2,143
Total identifiable assets	42,273
Noncontrolling interest	53,657
Goodwill, including noncontrolling interest of $34,409	$	86,412

Pro Forma Consolidated Income Statement Information

The following table contains unaudited pro forma consolidated income statement information assuming the 2017 acquisitions closed January 1, 2016 (amount in thousands, except earnings per share):



	2017		2016
Net service revenue		1,126,909		1,043,166



Operating income	78,317	73,779
Net income	52,300	38,520
Basic earnings per share	2.95	2.19
Diluted earnings per share	2.91	2.18